Cisplatin Resistance in an Ovarian Carcinoma Is Associated With a Defect in Programmed Cell Death Control Through XIAP Regulation (Q33873995)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 1, 2003
edit
Language Label Description Also known as
English
Cisplatin Resistance in an Ovarian Carcinoma Is Associated With a Defect in Programmed Cell Death Control Through XIAP Regulation
scientific article published on January 1, 2003

    Statements

    Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation (English)
    Cisplatin Resistance in an Ovarian Carcinoma Is Associated With a Defect in Programmed Cell Death Control Through XIAP Regulation (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit